Elicio Therapeutics, Inc.
ELTX
$8.05
$0.091.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.23% | -56.49% | -76.72% | 4.34% | -47.30% |
| Total Depreciation and Amortization | -4.14% | 6.64% | 6.23% | -41.52% | 163.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.44% | 219.90% | 2,081.65% | -3,467.01% | 375.33% |
| Change in Net Operating Assets | 87.18% | 326.21% | -63.03% | 150.64% | -307.37% |
| Cash from Operations | 16.52% | 11.63% | -40.29% | 5.77% | -48.94% |
| Capital Expenditure | -- | -- | 100.00% | -950.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -240.00% | 117.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -6.31% | -96.76% | 19,193.33% | 1,070.37% | 27,460.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | -6.31% | -96.76% | 51,156.67% | -98.53% | 9.80% |
| Foreign Exchange rate Adjustments | -- | -- | 1,700.00% | -1,950.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.92% | -194.92% | 555.03% | -172.07% | -158.12% |